IgGenix, Inc
WE'RE HIRING: http://iggenix.com/#careers
South San Francisco, United States
6 employees
Series B
Total: $75.00M
Biotechnology, Health Care
General Information
South San Francisco, United States
BounceWatch is an independent company data service, not affiliated with IgGenix, Inc. To contact IgGenix, Inc, visit iggenix.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About IgGenix, Inc
Taxonomy: venture backed, early-stage, Stanford University, allergy research, clinical research, innovation, biomedical technology, startup, South San Francisco, science, research collaboration, Steve Quake, Kari Nadeau
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | $40.00M | 5 |
|
01 Feb 2023 |
| Series A | Undisclosed | 1 |
|
01 Apr 2022 |
| Series A | $25.00M | 5 |
|
01 Jul 2021 |
| Series A | $10.00M | 2 |
|
01 Aug 2020 |
| Early VC | Undisclosed | 1 |
|
01 Sep 2019 |
| Spinout | Undisclosed | 1 |
Stanford University
|
01 Jan 2019 |
IgGenix, Inc Alternatives & Competitors
View All Alternatives
Solving fundamental problems in drug discovery to create a new generation of therapeutics.
Tech transfer & commercialization for the University of Nebraska Medical Center and the University o...
Antibody Manufacturer and Supplier | High-Quality Rabbit and Goat Monoclonal Antibodies
FAQ About IgGenix, Inc
Source: BounceWatch company record for IgGenix, Inc, https://bouncewatch.com/company/iggenix-inc, updated 9 June 2026. When citing, please name BounceWatch and link this page.
